‘Blue Beetle’ beats ‘Barbie’ in theatres

LOS ANGELES — It was a good news/bad news weekend for “Blue Beetle”, the latest superhero film to hit North American theatres and the first built around a live-action Latino protagonist.

The DC Studios/Warner Bros. production topped the charts for the Friday-through-Sunday period and even dethroned “Barbie”, that reigning queen of pinkness, industry watcher Exhibitor Relations said Sunday.

But its estimated take of $25.4 million was “the lowest DC superhero debut of this era” other than 2021’s money-losing “Wonder Woman 1984”.

“Beetle” stars 22-year-old American actor Xolo Mariduena — who is of mixed Mexican, Cuban and Ecuadoran descent — as a new college graduate whose body is taken over by the mysterious Scarab, which gives him superhuman powers.

Analyst David A. Gross said that while ticket sales for “Beetle” were only a third the average for new superhero flicks, reviews have been good and overseas prospects are strong.

“Barbie”, in its fifth week out, scored $21.5 million in ticket sales, “a huge result at this point in its theatrical run”, according to Variety. The Warner Bros. fantasy-comedy has now taken in an eye-popping $1.27 billion globally.

In third, also in its fifth week out, was Universal’s “Oppenheimer”, at $10.6 million. The historical drama about the origins of the first atomic bomb has passed the $700 million mark globally.

Fourth place went to Paramount’s animated “Teenage Mutant Ninja Turtles: Mutant Mayhem”, at $8.4 million. Its huge voice cast includes Maya Rudolph, Ayo Edebiri, John Cena, Jackie Chan, Ice Cube and Paul Rudd.

And in fifth was Universal’s new talking-dog comedy “Strays”, at $8.3 million, a concerning start for a movie made on a $46 million budget.

Rounding out the top 10 were “Meg 2: The Trench” ($6.7 million), “Talk to Me” ($3.2 million), “Haunted Mansion” ($3 million), “Mission: Impossible — Dead Reckoning Part One” ($2.7 million) and “The Last Voyage of the Demeter” ($2.5 million).

.col-lg-12.second .opinion-widget{border-top:1px solid #D0D0D0;} #widget_1623 .opinions-title {font-size:32px;}

{{articles_filter_1623_widget?.title}}

.epaper-separator{ height: 1px; width: 100%; background-color: #D0D0D0; margin: 15px 0; }

Today’s Paper

.related-articles .layout-ratio{padding-bottom:55%;}
.alert-success { color :#A3656F ; } .alert-danger { color : red ; } .footer { font-family:Myriad Pro,Arial; }
document.addEventListener('DOMContentLoaded', function () { function validateEmail(email) { return /^[^\s@]+@[^\s@]+\.[^\s@]+$/.test(email); } function showModal(message,type) { const messageContainer = document.getElementById("messageContainerFooter"); messageContainer.textContent = message; messageContainer.className = `alert alert-${type} mt-3`; // Bootstrap alert styling messageContainer.classList.remove("d-none"); // Hide message after 5 seconds setTimeout(() => { messageContainer.classList.add("d-none"); }, 5000); } document.getElementById("emailFormFooter").addEventListener("submit", function(event) { event.preventDefault(); const emailInput = document.getElementById("emailFooter"); const email = emailInput.value.trim(); if (!validateEmail(email)) { showModal('Invalid email format','danger'); return; } const url = `/subscribeNewsletter?email=${encodeURIComponent(email)}`; fetch(url, { method: "GET", headers: { "Accept": "application/json" } }) .then(response => { if (!response.ok) { showModal("Error submitting email. Try again.",'danger'); } return response.json(); }) .then(data => { showModal(data.message,'success'); }) .catch(error => { showModal("Error submitting email. Try again.",'danger'); }); }); });